Celsius vs. Dutch Bros: Which Growth Stock Wins in This Market?

Celsius is benefiting from the Alani Nu acquisition and is projected to lift revenue 20% from 2026 to 2028, with diluted EPS expected to grow 55% over the same period. Dutch Bros reported 2025 revenue growth of 27.9% and net income growth of 76.4%, with store count rising to 1,136 and a target of 2,029 locations by 2029. The article is broadly constructive on both companies, though it argues Dutch Bros trades at a richer valuation on 2028 EPS estimates.

Analysis

The market is likely underestimating how different the two growth stories are from a capital-allocation standpoint. CELH’s next leg is more dependent on keeping velocity high in an increasingly crowded functional-beverage aisle, where shelf placement and promotional intensity can erode unit economics faster than headline revenue growth suggests. BROS, by contrast, is still in a high-openings phase where each incremental store can compound brand awareness and throughput, so the operating leverage inflection is more durable as long as unit-level payback stays intact.

The second-order risk for CELH is channel conflict: after an acquisition-led broadened portfolio, it becomes easier to win distribution but harder to preserve pricing power if retailers start using adjacent brands as leverage. That makes earnings quality more fragile than the consensus EPS growth implies, because mix benefits and promo cadence can offset top-line gains. For BROS, the bigger swing factor is not comps in the next quarter but whether expansion into food and broader daypart usage can lift average ticket enough to defend returns once the easy same-store gains normalize.

On a relative basis, the “cheaper” stock may actually be the one with more hidden operational optionality. CELH can still work as a tactical momentum name if category sell-through remains strong, but its valuation leaves less room for a slowdown in household penetration or a competitive response from larger beverage players. BROS trades richer for a reason: if management executes on store growth and operating leverage, the market could keep awarding a scarcity premium to a consumer concept that still has multi-year white space.

The contrarian read is that the better risk/reward may be less about which company grows faster through 2028 and more about which one can convert growth into repeatable economics. Investors may be overpaying for visible EPS acceleration at CELH while underappreciating how much of BROS’s valuation is really a call option on scaling efficiency and a maturing brand moat.

Key Decisions for Investors

• Long BROS / short CELH as a 6-12 month pair trade: BROS offers better visibility on unit growth and operating leverage, while CELH faces tougher competitive substitution risk; target 15-20% relative outperformance if store openings and comps stay intact.
• If initiating CELH, prefer a tactical long only on post-earnings weakness with a 1-3 month horizon; risk/reward is acceptable only if management re-accelerates category share, otherwise multiple compression can be sharp.
• Use call spreads on BROS rather than stock for a 6-9 month horizon: the premium valuation limits downside asymmetry, but continued same-store sales strength can still drive upside if the market starts pricing the 2029 store target earlier.
• Avoid pairing either name against broad consumer staples; this is a stock-specific execution story, not a macro beverage call. Best hedge for CELH longs is shorting another functional-beverage or specialty beverage winner if liquidity allows.
• Trim CELH on any sign of trade-down or retailer promo escalation; in a 3-6 month window, margin compression would likely matter more than revenue beats.